Under construction – not a live service

Skip to content

Frontlight Research

Search a disease

Frequently searched

↑ ↓ to move · Enter to open · Esc to closeSynonyms and typos are matched

Home/Doctors/Parkinson disease

For doctors

Parkinson disease: trials for referral

948 open trials in the registries we read. Each row links to its registry record.

Registry data only. Frontlight does not judge whether a patient can take part: the trial team decides.

Parkinson disease·What we know·Glossary

Where the open trials are

Type a city to sort by distance. The distance is worked out in your browser; the city is not sent anywhere.

Your city

Only trials with a pre-treatment window

400 trials shown · Showing the 400 most recently updated of 948 open trials.

No phase1 site
Not yet recruitingUnited States
NCT07923201
Evaluating the Effect of the Zeen Mobility Device on Clinical Practicality, Safety, and Impact (Via Assessments of Walking, Standing Tolerance, Balance, Endurance, Effort, and Participation in Daily Tasks) in an Outpatient Rehabilitation Setting for Individuals With Mobility Impairments.
Casa Colina Hospital and Centers for Healthcare
Registry updated 6 Nov 2026
Registry record: ClinicalTrials.gov
Compare criteriaReferral pack Letter to the site
No phase1 site
Not yet recruitingSouth Korea
NCT07764874
Unilateral and Staged Bilateral Pallidothalamic Tractotomy Using Exablate MRgFUS in Advanced Parkinson's Disease.
InSightec
Registry updated 6 Nov 2026
Registry record: ClinicalTrials.gov
Compare criteriaReferral pack Letter to the site
No phase0 sites
Not yet recruiting
NCT06293118
The Effects of Ischemic Conditioning in Individuals With Parkinson's Disease
Hospital Israelita Albert Einstein
Registry updated 6 Nov 2026
Registry record: ClinicalTrials.gov
Compare criteriaReferral pack Letter to the site
Phase 3196 sites
RecruitingAustria, Australia, Brazil, Canada, China, Germany
NCT07174310
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Hoffmann-La Roche
Registry updated 5 Nov 2026
Registry record: ClinicalTrials.gov
Compare criteriaReferral pack Letter to the site
No phase1 site
RecruitingUnited States
NCT06778135
Neocortical Microarchitecture of Executive Function
University of Colorado, Denver
Registry updated 5 Nov 2026
Registry record: ClinicalTrials.gov
Compare criteriaReferral pack Letter to the site
No phase1 site
RecruitingUnited States
NCT07399496
Accelerated rTMS for Apathy in Parkinson's Disease
Medical University of South Carolina
Registry updated 5 Nov 2026
Registry record: ClinicalTrials.gov
Compare criteriaReferral pack Letter to the site
No phase1 site
Not yet recruitingPakistan
NCT07308093
Comparative Effects of Virtual Reality and Proprioceptive Neuromuscular Facilitation in Patients With Parkinson's Disease
Lahore University of Biological and Applied Sciences
Registry updated 5 Nov 2026
Registry record: ClinicalTrials.gov
Compare criteriaReferral pack Letter to the site
No phase1 site
RecruitingUnited States
NCT01581580
Deep Brain Stimulation Surgery for Movement Disorders
National Institute of Neurological Disorders and Stroke (NINDS)
Registry updated 5 Nov 2026
Registry record: ClinicalTrials.gov
Compare criteriaReferral pack Letter to the site
Phase 11 site
RecruitingSouth Korea
NCT07371338
Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients
Innopeutics Corporation
Registry updated 5 Nov 2026
Registry record: ClinicalTrials.gov
Compare criteriaReferral pack Letter to the site
Phase 1/21 site
RecruitingUnited States
NCT07863180
Tributyrin for Progressive Supranuclear Palsy (PSP): Virtual Trial
Prabesh Kanel
Registry updated 5 Nov 2026
Registry record: ClinicalTrials.gov
Compare criteriaReferral pack Letter to the site
Phase 1/21 site
RecruitingChina
NCT07733349
Phase I/II Clinical Trial of UX-DA003 Injection for the Treatment of Patients With Parkinson's Disease
Shanghai UniXell Biotechnology Co., Ltd
Registry updated 4 Nov 2026
Registry record: ClinicalTrials.gov
Compare criteriaReferral pack Letter to the site
No phase1 site
RecruitingItaly
NCT07066137
Motor Learning in Health and Movement Disorders: Role of Physical Activity and Advanced Devices
IRCCS Centro Neurolesi Bonino Pulejo
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.gov
Compare criteriaReferral pack Letter to the site
Phase 21 site
RecruitingUnited Kingdom
NCT07157735
A Trial to Test the Use of Dapansutrile, an Anti-inflammatory Medication, in People With Parkinson's Disease
Cambridge University Hospitals NHS Foundation Trust
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.gov
Compare criteriaReferral pack Letter to the site
No phase0 sites
Not yet recruiting
NCT07908498
Non-invasive Vagus Nerve Stimulation for Parkinson's Disease
Chinese University of Hong Kong
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.gov
Compare criteriaReferral pack Letter to the site
No phase1 site
By invitation onlyUnited States
NCT07534397
Treatment of Cognitive and Sensorimotor Deficits in Parkinson's Disease With High Definition Transcranial Direct Current Stimulation
The University of Texas at Dallas
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.gov
Compare criteriaReferral pack Letter to the site
Phase 11 site
Not yet recruitingUnited States
NCT07267065
AAV2-hAADC for Parkinson's Disease (PDCS-01)
Russell Lonser
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.gov
Compare criteriaReferral pack Letter to the site
Early Phase 11 site
RecruitingChina
NCT07911670
Exploratory Clinical Trial of UX-DA003 Injection for the Treatment of Patients With Parkinson's Disease
The First Affiliated Hospital of Anhui Medical University
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.gov
Compare criteriaReferral pack Letter to the site
No phase1 site
RecruitingSweden
NCT07820189
Effects of Microelectrode-based Brain Stimulation in Humans
Lund University
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.gov
Compare criteriaReferral pack Letter to the site
Phase 11 site
Not yet recruitingUnited States
NCT07914387
Stanford University Neurofiber Study
Stanford University
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.gov
Compare criteriaReferral pack Letter to the site
Phase 343 sites
RecruitingAustralia, Canada, United States
NCT06944522
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
BlueRock Therapeutics
Registry updated 2 Nov 2026
Registry record: ClinicalTrials.gov
Compare criteriaReferral pack Letter to the site
Phase 10 sites
Not yet recruiting
NCT07905976
Safety and Tolerability of Single and Repeated Dose of IMM02-KORA in PD-associated Dyskinesia
Immunis, Inc.
Registry updated 30 Oct 2026
Registry record: ClinicalTrials.gov
Compare criteriaReferral pack Letter to the site
Phase 26 sites
Not yet recruitingSwitzerland
NCT06431971
Estimates of the Efficacy of Talineuren (TLN) and Placebo in Patients With Parkinson Disease
InnoMedica Schweiz AG
Registry updated 30 Oct 2026
Registry record: ClinicalTrials.gov
Compare criteriaReferral pack Letter to the site
Phase 2/329 sites
RecruitingUnited States
NCT07284784
A Study of Buntanetap in Participants With PD
Annovis Bio Inc.
Registry updated 30 Oct 2026
Registry record: ClinicalTrials.gov
Compare criteriaReferral pack Letter to the site
No phase1 site
RecruitingUnited States
NCT07808346
Investigating Basal Ganglia-Cortical Physiology During Sleep and Its Modulation by Adaptive Deep Brain Stimulation in Parkinson Disease
University of Colorado, Denver
Registry updated 30 Oct 2026
Registry record: ClinicalTrials.gov
Compare criteriaReferral pack Letter to the site
Phase 276 sites
RecruitingSpain, United Kingdom, Israel, Italy, Poland, United States
NCT06680830
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
Neuron23 Inc.
Registry updated 30 Oct 2026
Registry record: ClinicalTrials.gov
Compare criteriaReferral pack Letter to the site
Phase 218 sites
RecruitingCanada, United States
NCT06996652
An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)
Yale University
Registry updated 30 Oct 2026
Registry record: ClinicalTrials.gov
Compare criteriaReferral pack Letter to the site
Phase 24 sites
Not yet recruitingUnited States
NCT07215403
Open-Label, Multi-Stage Study to Optimize the Intraputaminal Administration of AB-1005 Using a Prescriptive Infusion Algorithm (PIA)
AskBio Inc
Registry updated 29 Oct 2026
Registry record: ClinicalTrials.gov
Compare criteriaReferral pack Letter to the site
No phase1 site
By invitation onlySouth Korea
NCT07569133
Efficacy of Repetitive Transcranial Magnetic Stimulation for Improving Depressive Symptoms in Patients With Parkinson's Disease
Ho-Won Lee
Registry updated 29 Oct 2026
Registry record: ClinicalTrials.gov
Compare criteriaReferral pack Letter to the site
No phase1 site
RecruitingNetherlands
NCT06399731
Non-invasive Brain Stimulation for the Treatment of Mild Cognitive Impairment in Parkinson's Disease
Amsterdam UMC
Registry updated 29 Oct 2026
Registry record: ClinicalTrials.gov
Compare criteriaReferral pack Letter to the site
Phase 20 sites
Not yet recruiting
NCT07903038
Lemborexant on Perioperative Sleep Quality in Patients With Parkinson's Disease Undergoing Deep Brain Stimulation
Beijing Tiantan Hospital
Registry updated 29 Oct 2026
Registry record: ClinicalTrials.gov
Compare criteriaReferral pack Letter to the site

407 sites Pre-treatment window

The same sites as a list

Who treats this

Institutions with trials or publications in this disease (OpenAlex, registries). Institutions only, no people.

Aarhus University
Aarhus, Denmark
4 trials · 116 publications · ROR
All India Institute of Medical Sciences
New Delhi, India
1 trial · 109 publications · ROR
Amsterdam University Medical Centers
Amsterdam, Netherlands
6 trials · 147 publications · ROR
Assistance Publique – Hôpitaux de Paris
Paris, France
10 trials · 150 publications · ROR
Barrow Neurological Institute
Phoenix, United States
8 trials · 98 publications · ROR
Baylor College of Medicine
Houston, United States
11 trials · 142 publications · ROR
Beijing Tian Tan Hospital
Beijing, China
2 trials · 170 publications · ROR
Beth Israel Deaconess Medical Center
Boston, United States
19 trials · 100 publications · ROR
Boston University
Boston, United States
6 trials · 98 publications · ROR
Brigham and Women's Hospital
Boston, United States
5 trials · 156 publications · ROR
Cairo University
Giza, Egypt
1 trial · 124 publications · ROR
Case Western Reserve University
Cleveland, United States
1 trial · 121 publications · ROR
Charité – Universitätsmedizin Berlin
Berlin, Germany
10 trials · 141 publications · ROR
Christian-Albrechts-Universität zu Kiel
Kiel, Germany
3 trials · 103 publications · ROR
Cleveland Clinic
Cleveland, United States
27 trials · 225 publications · ROR
Columbia University
New York, United States
9 trials · 160 publications · ROR
Columbia University Irving Medical Center
New York, United States
7 trials · 169 publications · ROR
Donders Institute for Brain, Cognition and Behaviour
Nijmegen, Netherlands
2 trials · 178 publications · ROR
Duke University
Durham, United States
9 trials · 127 publications · ROR
Emory University
Atlanta, United States
13 trials · 224 publications · ROR
Huashan Hospital
Shanghai, China
5 trials · 135 publications · ROR
Icahn School of Medicine at Mount Sinai
New York, United States
4 trials · 171 publications · ROR
Imperial College London
London, United Kingdom
1 trial · 183 publications · ROR
Innsbruck Medical University
Innsbruck, Austria
14 trials · 118 publications · ROR
Institut du Cerveau
Paris, France
1 trial · 172 publications · ROR
IRCCS San Raffaele Roma
Rome, Italy
8 trials · 91 publications · ROR
Istituto Neurologico Mediterraneo
Pozzilli, Italy
1 trial · 140 publications · ROR
Johns Hopkins University
Baltimore, United States
5 trials · 246 publications · ROR
Juntendo University
Tokyo, Japan
1 trial · 149 publications · ROR
Karolinska Institutet
Stockholm, Sweden
3 trials · 275 publications · ROR

What changed in the last 7 days

RSS feed (30 days)Calendar reminder

Registry facts, one per line, newest first.

6 Nov 2026
Status changed: Running, not recruiting → Completed
Mobility in Daily Life and Falls in Parkinson's Disease: Potential for Rehabilitation
NCT04897256 · No phase · United States
Source: ClinicalTrials.gov
6 Nov 2026
New in the registry
Evaluating the Effect of the Zeen Mobility Device on Clinical Practicality, Safety, and Impact (Via Assessments of Walking, Standing Tolerance, Balance, Endurance, Effort, and Participation in Daily Tasks) in an Outpatient Rehabilitation Setting for Individuals With Mobility Impairments.
NCT07923201 · No phase · United States
Source: ClinicalTrials.gov
6 Nov 2026
New in the registry
Compulsive Eating and Brain's Reward System in Different Pathologies
NCT07923513 · No phase · France
Source: ClinicalTrials.gov
6 Nov 2026
New in the registry
Voluntary Activation During Isokinetic Contractions in Subjects With Neuromotor Disorders
NCT04607174 · No phase · Italy
Source: ClinicalTrials.gov
6 Nov 2026
New in the registry
Treating Anxiety in Parkinson's Disease With a Multi-Strain Probiotic
NCT03968133 · Phase 2 · Canada
Source: ClinicalTrials.gov
6 Nov 2026
Closed for recruitment
Adaptive DBS to Offset STN Dysregulation During Exercise in PD
NCT06296810 · No phase · United States
Source: ClinicalTrials.gov
6 Nov 2026
Status changed: Running, not recruiting → Completed
Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD
NCT05819359 · Phase 2 · Canada, Germany, Spain, France, United Kingdom, Italy
Source: ClinicalTrials.gov
6 Nov 2026
New in the registry
Clinical Safety and Efficacy of Umbilical Cord Mesenchymal Stromal Cells-derived Exosomes in Patients With Parkinson's Disease
NCT07923838 · Phase 1/2 · China
Source: ClinicalTrials.gov
6 Nov 2026
Opened for recruitment
Early Molecular Biomarkers for Differentiating Parkinsonian Syndromes
NCT07604883 · No phase · Poland
Source: ClinicalTrials.gov
5 Nov 2026
New in the registry
A Study to Evaluate the Efficacy and Safety of CP-012B in Participants With Parkinson’s Disease With Early Morning OFF Episodes
2026-526634-46-00 · Phase 2 · Spain, Italy, Poland
Source: EU CTIS
5 Nov 2026
Closed for recruitment
A Digital Therapeutic Platform for Swallowing and Drooling Problems in Parkinson's
NCT04664634 · Phase 3 · United States
Source: ClinicalTrials.gov
5 Nov 2026
Closed for recruitment
Adapting rHIRE and Sleep Monitoring in Parkinson's Disease
NCT07498296 · No phase · United States
Source: ClinicalTrials.gov
5 Nov 2026
New in the registry
Longitudinal Observation of Neurodegeneration in Parkinson's Disease Using Molecular Imaging and Blood Biomarkers
NCT07919262 · No phase
Source: ClinicalTrials.gov
5 Nov 2026
Closed for recruitment
Naturalistic Sleep Assessed by Wearable Devices in Parkinson Disease
NCT05348837 · No phase · United States
Source: ClinicalTrials.gov
5 Nov 2026
Closed for recruitment
Myrosinase Bioactivated Gglucoraphanin for the Treatment of Neurodegenerative Diseases (GRA-MYR-ND)
NCT07360977 · No phase · Italy
Source: ClinicalTrials.gov
20 Oct 2026
Phase changed: Phase 2 → Phase 1/2
Study to Test Effects and Safety of RO7568282 in Early Parkinson's Disease
NCT07781644 · Phase 1/2 · Austria, Germany, Spain, France, United Kingdom, Ireland
Source: ClinicalTrials.gov
31 Jul 2026
Phase changed: Phase 1 → Early Phase 1
Test-retest Trial With [11C]MODAG-005 in PD or MSA and AMHC - Pilot Phase
NCT07640542 · Early Phase 1 · Germany
Source: ClinicalTrials.gov
22 Oct 2026
Opened for recruitment
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
NCT06976268 · Phase 2/3 · Austria, Belgium, Czechia, Germany, Spain, France
Source: ClinicalTrials.gov
28 Oct 2026
Phase changed: Phase 1 → Early Phase 1
[18F]ACI-15916 PET in α-synucleinopathies
NCT06891703 · Early Phase 1 · Sweden
Source: ClinicalTrials.gov
17 Apr 2026
Status changed: Completed → Running, not recruiting
To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications
NCT06553027 · Phase 3 · Australia, Czechia, Spain, France, United Kingdom, Italy
Source: ClinicalTrials.gov

Show more

17 Apr 2026
Phase changed: Phase 2 → Phase 3
To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications
NCT06553027 · Phase 3 · Australia, Czechia, Spain, France, United Kingdom, Italy
Source: ClinicalTrials.gov
1 Oct 2026
Closed for recruitment
A Study to Evaluate the Effects of ACI-7104.056 in Patients With Early Stages of Parkinson's Disease
NCT06015841 · Phase 2 · Germany, Spain, United Kingdom
Source: ClinicalTrials.gov
4 Sept 2026
Phase changed: Phase 2/3 → Phase 2
A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease
NCT04777331 · Phase 2 · Austria, Canada, Spain, France, United Kingdom, Italy
Source: ClinicalTrials.gov
3 Sept 2026
Status changed: Completed → Running, not recruiting
Safety, Tolerability, Pharmacokinetics and Efficacy Study of Radotinib in Parkinson's Disease
NCT04691661 · Phase 2 · France
Source: ClinicalTrials.gov
11 Sept 2026
Closed for recruitment
A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease
NCT03100149 · Phase 2 · Austria, Germany, Spain, France, United States
Source: ClinicalTrials.gov
2 Sept 2026
Opened for recruitment
A Study to Evaluate the Effects of ACI-7104.056 in Patients With Early Stages of Parkinson's Disease
NCT06015841 · Phase 2 · Germany, Spain, United Kingdom
Source: ClinicalTrials.gov
12 May 2026
Opened for recruitment
A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease
NCT03100149 · Phase 2 · Austria, Germany, Spain, France, United States
Source: ClinicalTrials.gov
26 Aug 2026
Status changed: Recruiting → Not yet recruiting
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
NCT06976268 · Phase 2/3 · Austria, Belgium, Czechia, Germany, Spain, France
Source: ClinicalTrials.gov
4 Nov 2026
New in the registry
Efficacy of Split Gait in the Treatment of Dynamic Asymmetries in Subjects With Pathologic Claudication
NCT04635436 · No phase · Italy
Source: ClinicalTrials.gov
4 Nov 2026
Closed for recruitment
MR-guided Focused Ultrasound Plus GCase
NCT05565443 · No phase · Canada
Source: ClinicalTrials.gov
4 Nov 2026
Opened for recruitment
Phase I/II Clinical Trial of UX-DA003 Injection for the Treatment of Patients With Parkinson's Disease
NCT07733349 · Phase 1/2 · China
Source: ClinicalTrials.gov
4 Nov 2026
Closed for recruitment
Role of Silymarin in Neuroprotection and Symptom Management in Parkinson's Disease
NCT07001150 · Phase 2 · Egypt
Source: ClinicalTrials.gov
4 Nov 2026
New in the registry
Early COMT Inhibition in PD
NCT07917546 · No phase · Italy
Source: ClinicalTrials.gov
4 Nov 2026
Opened for recruitment
Effect of Hand Rehabilitation on Cognitive Function in Patients With PD
NCT07702929 · No phase · Iran
Source: ClinicalTrials.gov
6 Apr 2026
Phase changed: No phase → Phase 2
The Swedish BioFINDER 2 Study
NCT03174938 · Phase 2 · Sweden
Source: ClinicalTrials.gov
2 Feb 2026
Phase changed: No phase → Phase 1
Quantification of Hsp90 in the Human Brain
NCT07380204 · Phase 1 · Belgium
Source: ClinicalTrials.gov
3 Nov 2026
Status changed: Running, not recruiting → Completed
Genotypic Influences on Network Progression in Parkinson's Disease
NCT04228172 · No phase · United States
Source: ClinicalTrials.gov
3 Nov 2026
Status changed: Recruiting → By invitation only
Treatment of Cognitive and Sensorimotor Deficits in Parkinson's Disease With High Definition Transcranial Direct Current Stimulation
NCT07534397 · No phase · United States
Source: ClinicalTrials.gov
3 Nov 2026
Opened for recruitment
Effects of Microelectrode-based Brain Stimulation in Humans
NCT07820189 · No phase · Sweden
Source: ClinicalTrials.gov
3 Nov 2026
Opened for recruitment
Motor Learning in Health and Movement Disorders: Role of Physical Activity and Advanced Devices
NCT07066137 · No phase · Italy
Source: ClinicalTrials.gov

New reviews, guidelines and randomised trials in PubMed

6 Nov 2026
Systematic review
Impact of Particulate Matter Exposure on Neurological Health in Older Adults: A Systematic Review.
Current environmental health reports · PubMed
6 Nov 2026
Meta-analysis
Serum Insulin-Like Growth Factor-1 (IGF-1) in Parkinson's Disease: A Systematic Review and Meta-Analysis.
Brain and behavior · PubMed
6 Nov 2026
Systematic review
Compound heterozygous and digenic inheritance in early-onset Parkinson's disease: a systematic review.
Frontiers in aging neuroscience · PubMed
5 Nov 2026
Systematic review
Prognostic factors for cognitive intervention responsiveness in Parkinson's disease: a systematic review revealing inconsistent methodology and evidence.
Frontiers in cognition · PubMed
4 Nov 2026
Meta-analysis
Efficacy of cognitive behavioral therapy for anxiety and depression symptoms in Parkinson's disease patients: a systematic review and meta-analysis.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · PubMed
3 Nov 2026
Systematic review
[Molecular biomarkers for multiple system atrophy. (A systematic review)].
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · PubMed
3 Nov 2026
Systematic review
Singing-based interventions for motor and non-motor symptoms in Parkinson's disease: a systematic review.
Journal of neurology · PubMed
3 Nov 2026
Systematic review
Transcranial Pulse Stimulation in Parkinson's Disease: A Systematic Review.
Brain and behavior · PubMed
3 Nov 2026
Systematic review
Infection-related research in Parkinson's disease: an exploratory trends analysis.
Frontiers in aging neuroscience · PubMed

Results card

Trials that finished or stopped in the last 3 years, with the reason the registry gives and linked publications.

No phaseEnded Oct 2026
Withdrawn before start0 participants
NCT05685095
Programmes de Marche Active et qualité de Vie Dans la Maladie de Parkinson
Reason given: personnel involved in clinical trial will not be available to conduct the research
Registry record
Phase 1Ended Oct 2026
Stopped early34 participants
NCT02897063
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
Reason given: enrollment goal was not met.
Registry record
No phaseEnded 30 Oct 2026
Withdrawn before start0 participants
NCT06118294
Efficacy of Probiotics for Parkinson Disease (PD)
Reason given: PI has retired
Registry record
No phaseEnded 21 Oct 2026
Completed16 participants
NCT07498296
Adapting rHIRE and Sleep Monitoring in Parkinson's Disease
Registry record
No phaseEnded 16 Oct 2026
Completed39 participants
NCT07641569
Comparison of Two Different Dual-Task Training Methods in Patients With Parkinson's Disease
Registry record
No phaseEnded 14 Oct 2026
Completed58 participants
NCT05773885
Telerehabilitation in People With Parkinson's Disease
Registry record
No phaseEnded 14 Oct 2026
Completed42 participants
NCT06906679
Upper Limb Rehabilitation in People With Parkinson's Disease:
Registry record
Phase 3Ended 9 Oct 2026
Completed59 participants
NCT04664634
A Digital Therapeutic Platform for Swallowing and Drooling Problems in Parkinson's
Registry record
No phaseEnded 29 Sept 2026
Completed5 participants
NCT06695455
The Effect of an Auditory Rhythmic Cue on the Frequency of Rolling in Patients With Dysphagia and Parkinson's Disease
Registry record
No phaseEnded 15 Sept 2026
Completed31 participants
NCT07859566
Home-Based Exercise Program After Community Balance Training for Parkinson's Disease
Registry record
Phase 1Ended 10 Sept 2026
Completed200 participants
2023-509158-68-00
First in human study in healthy volunteers and participants with Parkinsons disease with and without GBA1 mutations.
Registry record
Phase 2Ended 9 Sept 2026
Completed273 participants
NCT05819359
Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD
Registry record
No phaseEnded 31 Aug 2026
Stopped early1 participant
NCT07313176
Long Term Effectiveness of Levodopa-Entacapone-Carbidopa Intestinal Gel in Participants With Advanced Parkinson's Disease
Reason given: Following a reassessment, it was concluded that continuation of the study would no longer achieve its scientific objectives originally set out for the study.
Registry record
Phase 1/2Ended Aug 2026
Paused86 participants
NCT03575195
Microbiota Intervention to Change the Response of Parkinson's Disease
Reason given: Conducting an interim analysis
Registry record
No phaseEnded 30 Aug 2026
Completed50 participants
NCT07442370
The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients
- Effects of Structured Functional Turning Practice Within a Time-Matched Exercise Program on Functional Mobility, Gait Speed, and Balance in Early-Stage Parkinson's Disease: A Randomized Controlled Trial. · Journal of clinical medicine, 2026
Registry record
No phaseEnded 30 Aug 2026
Completed350 participants
NCT04453033
DB RCT for Specialized Phototherapy in Parkinson's Disease.
Registry record
No phaseEnded 24 Aug 2026
Completed13 participants
NCT06225830
Unlocking Movement Potential: Enhancing Parkinson's Disease Treatment With Robotic EksoSkeleton
Registry record
Phase 2Ended 24 Aug 2026
Completed81 participants
NCT05931575
Safety, Tolerability and Symptomatic Efficacy of the ROCK-Inhibitor Fasudil in Patients With Parkinson's Disease
Registry record
Phase 2/3Ended 20 Aug 2026
Completed60 participants
NCT06113640
Montelukast in Parkinson Disease
Registry record
No phaseEnded 17 Aug 2026
Completed18 participants
NCT07887802
Multimodal Rehabilitation and Balance Assessment in Parkinson's Disease
Registry record

Show more

Phase 2Ended 10 Aug 2026
Completed38 participants
NCT06671938
Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease and Patients With Multiple System Atrophy
Registry record
No phaseEnded 1 Aug 2026
Completed96 participants
NCT07572903
The Efficacy and Safety of Temporal Interference Stimulation on Motor Symptoms of Parkinson's Disease
Registry record
No phaseEnded 1 Aug 2026
Completed28 participants
NCT07590700
Home-Based Exercise Programs for Fall Prevention in Parkinson Disease
Registry record
Phase 1Ended Jul 2026
Withdrawn before start0 participants
NCT06498687
Theophylline Nasal Spray for PD-Related Hyposmia and Anosmia
Reason given: sponsor discontinued site participation
Registry record
Early Phase 1Ended 20 Jul 2026
Stopped early16 participants
NCT07348250
Open-label Study to Evaluate Brain α-Synuclein Deposition Using PET and [18F]MK-0947 in Parkinson's Disease
Reason given: Study terminated due to site closure.
Registry record
No phaseEnded 17 Jul 2026
Completed42 participants
NCT07495462
Effect of Motor Imagery Added to Rehabilitation on Balance and Kinesiophobia in Patients With Parkinson's Disease
Registry record
No phaseEnded 15 Jul 2026
Paused180 participants
NCT04501133
Sensory-specific Peripheral Stimulation for Tremor Management
Reason given: Study pending of funding that could not be secured
Registry record
No phaseEnded 15 Jul 2026
Completed89 participants
NCT03648905
Clinical Laboratory Evaluation of Chronic Autonomic Failure
Registry record
No phaseEnded 9 Jul 2026
Completed42 participants
NCT07723027
Effects of Whole Body Vibration Versus Proprioceptive Neuromuscular Facilitation Pattern With Rhythmic Based Training on Clinical Outcomes in Patients With Parkinson's Disease.
Registry record
No phaseEnded 1 Jul 2026
Completed55 participants
NCT04897256
Mobility in Daily Life and Falls in Parkinson's Disease: Potential for Rehabilitation
Registry record
No phaseEnded 30 Jun 2026
Completed30 participants
NCT04101968
The GBA Multimodal Study in Parkinson's Disease
Registry record
No phaseEnded 30 Jun 2026
Completed33 participants
NCT06713265
Study of the Link Between Freezing of Gait and Oropharyngeal Freezing in Parkinson's Patients
Registry record
No phaseEnded 30 Jun 2026
Completed20 participants
NCT04620551
Adaptive Neurostimulation to Restore Sleep in Parkinson's Disease
- Shared Spectral Parameters Between EEG and Basal Ganglia LFP Distinguish Sleep-Specific Oscillations in Parkinson's Disease. · European journal of neurology, 2026
Registry record
No phaseEnded 30 Jun 2026
Completed42 participants
NCT05286736
Neuroplasticity in Parkinson's Disease
Registry record
No phaseEnded 30 Jun 2026
Completed116 participants
NCT06663826
Development of Digital Diagnostic Devices for Parkinson's Disease
Registry record
No phaseEnded 25 Jun 2026
Completed40 participants
NCT07772622
The Validity and Reliability of an Improved Paper Grasping Test for Parkinson's Disease
Registry record
No phaseEnded 25 Jun 2026
Completed30 participants
NCT06690931
Neurofeedback Rehabilitation With FES and VR for PD
Registry record
No phaseEnded 23 Jun 2026
Completed85 participants
NCT07731841
Transcranial Magnetic Stimulation for Freezing of Gait in Parkinson's Disease
Registry record
No phaseEnded 20 Jun 2026
Completed20 participants
NCT07361250
Subthalamic Nucleus (STN)-Targeted Transcranial Temporal Interference Stimulation (TIS) for Parkinson's Disease: Efficacy and Safety From a Single-Center, Prospective, Double-Blind Randomized Controlled Trial
Registry record
No phaseEnded 19 Jun 2026
Completed28 participants
NCT06861933
The Effects of Scapulohumeral Rehabilitation on Scapula Kinematics and Upper Extremity Functionality in Individuals With Parkinson's Disease
Registry record
Phase 1/2Ended 17 Jun 2026
Withdrawn before start0 participants
NCT07011771
A Clinical Trial of CAP-003 Gene Therapy in Adult Patients With GBA1 Associated Parkinson's Disease
Reason given: Per protocol stopping rule was met for a separate trial for a different disease state and different experimental therapy that utilized a similar technology.
Registry record
Early Phase 1Ended 15 Jun 2026
Completed88 participants
NCT06189170
Phase I Study to Evaluate KP405 in Healthy and Parkinson's Disease Patients
Registry record
No phaseEnded 15 Jun 2026
Completed34 participants
NCT07629063
Effectiveness of Resistance Exercises Added to Aerobic and Balance Exercises in Parkinson's Disease
Registry record
No phaseEnded 12 Jun 2026
Completed57 participants
NCT07274514
Virtual Reality on Balance of Parkinson's Disease
- Effects of a level-based immersive virtual reality physical therapy program on static and dynamic balance in Parkinson's disease: Protocol for a randomized controlled trial. · PloS one, 2026
Registry record
No phaseEnded 10 Jun 2026
Completed69 participants
NCT07536490
Sleep Quality, Cognition, and Disease Severity in Parkinson's Disease
Registry record
No phaseEnded 10 Jun 2026
Completed56 participants
NCT07264114
Aquatic High-Intensity Interval Training for Parkinson's Disease
Registry record
Phase 1Ended 3 Jun 2026
Completed40 participants
2025-520754-11-00
Phase I, Open-Label Study to Evaluate the Pharmacokinetics, Safety and Tolerability of BIA 28-6156 in Participants with Varying Degrees of Renal Impairment
Registry record
Phase 2Ended 31 May 2026
Completed57 participants
NCT06757010
A Study of NE3107 in Early Parkinson's
Registry record
Phase 2Ended 30 May 2026
Completed50 participants
NCT07001150
Role of Silymarin in Neuroprotection and Symptom Management in Parkinson's Disease
Registry record
Phase 1Ended 29 May 2026
Completed68 participants
2025-521357-17-00
To investigate the safety and efficacy of a novel investigational compound against neurological diseases such as Parkinson's disease in healthy men and women and patients with Parkinson's disease.
Registry record
No phaseEnded 21 May 2026
Completed120 participants
NCT07666477
rTMS and Olfactory Training for Parkinson's Disease
Registry record
No phaseEnded 13 May 2026
Completed3 participants
NCT07221994
Blood Flow Restriction and Exercise in Parkinson's Disease
Registry record
No phaseEnded 6 May 2026
Completed31 participants
NCT05720468
Exercise for Cognitive Excellence in Parkinson's Disease
- Home-Based, Virtually Supervised Combined Exercise Intervention in People With Parkinson Disease: Protocol for a Randomized Controlled Trial. · JMIR research protocols, 2026
Registry record
No phaseEnded 4 May 2026
Completed24 participants
NCT06295458
Gamma Sensory Flicker for Parkinson's Disease Patients With Freezing of Gait
Registry record
No phaseEnded 30 Apr 2026
Completed72 participants
NCT07800312
PechaKucha Versus PowerPoint for Parkinson's Disease Education in Nurses
Registry record
No phaseEnded Apr 2026
Withdrawn before start0 participants
NCT04381065
Utilization of Target Ranges to Treat Persons With Parkinson's Disease by Objective Measurement Using the PKG
Reason given: Business decision
Registry record
No phaseEnded 30 Apr 2026
Completed733 participants
NCT04553185
Aquaporin-4 Single Nucleotide Polymorphisms in Patients With Idiopathic and Familial Parkinson's Disease
Registry record
Phase 3Ended 27 Apr 2026
Completed118 participants
NCT04750226
Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinson's Disease
Registry record
No phaseEnded 17 Apr 2026
Completed76 participants
NCT07063810
NEO-REEDUC - Mixed Reality for Motor Rehabilitation: a Prospective, Multicenter, Controlled, Randomized, Open Study.
Registry record
Phase 3Ended 17 Apr 2026
Completed130 participants
NCT04379050
Extension Study To Evaluate Safety And Tolerability Of 24-Hour Daily Exposure Of Continuous Subcutaneous Infusion of ABBV-951 In Adult Participants With Parkinson's Disease
Registry record

Not medical advice. fetched 9 Nov 2026

Report an error

Frontlight Research

Medical research worldwide, searchable by disease and dated at every step.

Diseases

Acute myeloid leukemia
Alzheimer disease
Childhood cancers
Colorectal cancer
Gastric and esophageal cancer
Glioblastoma
Liver and biliary tract cancer
Long COVID and ME/CFS
Lung cancer
Metastatic breast cancer
Multiple myeloma
Multiple sclerosis
Ovarian cancer
Pancreatic cancer
Parkinson disease

All diseases A–Z

For you

Patients
Doctors
Researchers

About

About Frontlight
Data sources
How summaries are made
Editorial checks & sources
Contact

Not medical advice. Texts marked “Machine summary” are generated automatically from registry and publication data and can be wrong. Sources: ClinicalTrials.gov, EU CTIS, PubMed, OpenAlex; WHO ICTRP coming soon.

Terms
Privacy
Cookies
Imprint

© 2026 Frontlight Research

Under construction, not live – Parkinson disease: trials for referral – Frontlight Research